Louise Wang Zhiying Humphrey

Array ( [id] => 6252147 [patent_doc_number] => 20100028375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'VLP BASED VACCINE DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/444092 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12543 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028375.pdf [firstpage_image] =>[orig_patent_app_number] => 12444092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745300 [patent_doc_number] => 20080089902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/866146 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6464 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089902.pdf [firstpage_image] =>[orig_patent_app_number] => 11866146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745327 [patent_doc_number] => 20080089929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/866225 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6460 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089929.pdf [firstpage_image] =>[orig_patent_app_number] => 11866225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964849 [patent_doc_number] => 20080107669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHOD OF PRODUCING AN HIV-1 IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/865106 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7593 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107669.pdf [firstpage_image] =>[orig_patent_app_number] => 11865106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964850 [patent_doc_number] => 20080107670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHOD OF PRODUCING AN HIV-1 IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/865109 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7588 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107670.pdf [firstpage_image] =>[orig_patent_app_number] => 11865109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752434 [patent_doc_number] => 20080160507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'HIV capsid assembly-associated compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/903494 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14667 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160507.pdf [firstpage_image] =>[orig_patent_app_number] => 11903494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452599 [patent_doc_number] => 20090068636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'VIRAL PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/857961 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8560 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068636.pdf [firstpage_image] =>[orig_patent_app_number] => 11857961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9982724 [patent_doc_number] => 09028423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Distinguishing closed and open respiratory airway apneas by complex admittance values' [patent_app_type] => utility [patent_app_number] => 12/376136 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6614 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12376136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704138 [patent_doc_number] => 20080063662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 11/843815 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10523 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063662.pdf [firstpage_image] =>[orig_patent_app_number] => 11843815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 31782 [patent_doc_number] => 07790179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Homogeneous attenuated human rotavirus population' [patent_app_type] => utility [patent_app_number] => 11/843256 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10625 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790179.pdf [firstpage_image] =>[orig_patent_app_number] => 11843256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909632 [patent_doc_number] => 20080020398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'CROSS-REACTIVE PRIMERS FOR AMPLIFYING THE NUCLEIC ACIDS OF HIV-1 AND HIV-2' [patent_app_type] => utility [patent_app_number] => 11/837954 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23274 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020398.pdf [firstpage_image] =>[orig_patent_app_number] => 11837954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739905 [patent_doc_number] => 20080233558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Inhibitors of viral entry screening method' [patent_app_type] => utility [patent_app_number] => 11/888801 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12118 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233558.pdf [firstpage_image] =>[orig_patent_app_number] => 11888801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807418 [patent_doc_number] => 20080170996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Compositions and Methods for Stimulation of Lung Innate Immunity' [patent_app_type] => utility [patent_app_number] => 11/830622 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 24261 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20080170996.pdf [firstpage_image] =>[orig_patent_app_number] => 11830622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981866 [patent_doc_number] => 08512981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV' [patent_app_type] => utility [patent_app_number] => 12/306239 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 12202 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12306239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32855 [patent_doc_number] => 07785775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Human virus causing severe acute respiratory syndrome (SARS) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/808408 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 14 [patent_no_of_words] => 23951 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785775.pdf [firstpage_image] =>[orig_patent_app_number] => 11808408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588994 [patent_doc_number] => 20100291595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'BLOOD MONOCYTE CD163 EXPRESSION AS A BIOMARKER IN HIV-1 INFECTION AND NEUROAIDS' [patent_app_type] => utility [patent_app_number] => 12/301796 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12876 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291595.pdf [firstpage_image] =>[orig_patent_app_number] => 12301796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6578595 [patent_doc_number] => 20100047355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MAGNETIC RESONANCE-DETECTABLE, ULTRASOUND-DETECTABLE AND/OR RADIOPAQUE MICROCAPSULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/226648 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17235 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047355.pdf [firstpage_image] =>[orig_patent_app_number] => 12226648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480102 [patent_doc_number] => 20090203059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'PROTEASE DETECTION PRODUCT' [patent_app_type] => utility [patent_app_number] => 12/296413 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6749 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203059.pdf [firstpage_image] =>[orig_patent_app_number] => 12296413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711859 [patent_doc_number] => 20080300385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Covalently-linked complexes of HIV Tat and Env proteins' [patent_app_type] => utility [patent_app_number] => 11/729076 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15250 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300385.pdf [firstpage_image] =>[orig_patent_app_number] => 11729076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070163 [patent_doc_number] => 20070191265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Anti-HIV Agent' [patent_app_type] => utility [patent_app_number] => 11/691914 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7529 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191265.pdf [firstpage_image] =>[orig_patent_app_number] => 11691914 [rel_patent_id] =>[rel_patent_doc_number] =>)